StonvexLoading…
StonvexStonvexStonvexCore line items from NAVN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2026 2026-01-31 | Annual 2025 2025-01-31 | Annual 2024 2024-01-31 |
|---|---|---|---|
Revenue | $702.26M | $536.84M | $402.26M |
Operating Income | $-196.88M | $-107.64M | $-246.34M |
Net Income | $-398.03M | $-181.08M | $-331.55M |
EPS (Diluted) | $-4.07 | $-4.00 | $-7.44 |
Total Assets | $1.71B | $1.08B | Not available |
Total Liabilities | $500.70M | $969.73M | Not available |
Cash & Equivalents | $583.52M | $157.67M | $166.42M |
Free Cash Flow OCF − CapEx | $32.75M | $-51.40M | $-166.92M |
Shares Outstanding | 97.80M | 45.78M | 44.58M |